Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
SEC Accession No. 0001415889-25-013132
Filing Date
2025-05-15
Accepted
2025-05-15 16:17:09
Documents
2
Period of Report
2025-03-31
Effectiveness Date
2025-05-15

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 13F-HR  
1 primary_doc.xml 13F-HR 2026
2 form13f-1747340226_infotable.html INFORMATION TABLE  
2 form13f-1747340226_infotable.xml INFORMATION TABLE 2900
  Complete submission text file 0001415889-25-013132.txt   6138
Mailing Address 106 W 56TH ST. FLOOR 8 NEW YORK NY 10019
Business Address 106 W 56TH ST. FLOOR 8 NEW YORK NY 10019 212-909-3022
Enavate Sciences GP, LLC (Filer) CIK: 0001953107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 13F-HR | Act: 34 | File No.: 028-25306 | Film No.: 25953502